Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Feng Li, MD
CONTACT
Yu Qi
CONTACT
Lead
The First Affiliated Hospital of Zhengzhou University
With
In the phase II trial, the efficacy and safety of MRD-guided adjuvant tislelizumab and chemotherapy will be compared with that of standard adjuvant tislelizumab and chemotherapy in patients with resectable NSCLC.
Age
18–80
Sex
ALL
Healthy volunteers
Not accepted